Acura Pharmaceuticals Stock Price and Value Analysis

Should you buy Acura Pharmaceuticals stock? (Other OTC:ACUR). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This stock looks overpriced.
  • This company is not making money.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the ACUR Numbers

ACUR Price
(Acura Pharmaceuticals stock price per share)
[?] PE Ratio versus Sector 566% higher than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Unknown stocks
[?] Cash Yield -23.85%
[?] Free Cash Flow Jitter 621%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 89,846 shares shorted. With 7,505,419 shares available for purchase and an average trading volume over the past 10 trading days of 29,600, it would take at least 3.035 days for all of the short holders to cover their shorts.

Is Acura Pharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Acura Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ACUR Stock?

Does Acura Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.